Bioceres Crop Solutions (NASDAQ:BIOX) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.06) by 733.33 percent. This is a 34.21 percent increase over losses of $(0.76) per share from the same period last year. The company reported quarterly sales of $55.900 million which missed the analyst consensus estimate of $79.000 million by 29.24 percent. This is a 25.17 percent decrease over sales of $74.700 million the same period last year.